# LOPERAMIDE HYDROCHLORIDE
> **ANDA216876** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-01-26
## Drug
- **FDA Application Number:** ANDA216876
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOPERAMIDE HYDROCHLORIDE
- **Generic name:** LOPERAMIDE HYDROCHLORIDE
- **Active ingredients:** LOPERAMIDE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd.,
- **First approval:** 2023-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216876)
---
*AI Analytics · CC0 1.0*